PPP4R3A

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, PPP4R3A mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated PPP4R3A data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher PPP4R3A mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated PPP4R3A expression acts as an unfavorable survival marker, although some lineages such as LSCC and CCRCC show a favorable association.

LSCC, CCRCC, and HNSC are the cancer types where PPP4R3A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LSCCDFSQuartileII,III,IV0.9450.490.00225view →
CCRCCDFSTertileAll1.0000.686.01515view →
HNSCOSMedianIV0.7440.925.01115view →
PDACDFSTertileIV0.9340.235.0249view →
UCECDFSMedianAll0.9361.000.0222view →
GBMOSMedianAll0.5200.300.0341view →
LUADOSQuartileAll0.7081.000.0371view →
Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

PPP4R3A–LSCC (DFS)

Kaplan–Meier survival curve for PPP4R3A mass-spec protein-high vs -low samples in LSCC.

Open the LSCC breakdown →

Exploration